共 50 条
- [41] A prospective observational study with dose volume parameters predicting rectosigmoidoscopic findings and late rectosigmoid bleeding in patients with uterine cervical cancer treated by definitive radiotherapyRADIATION ONCOLOGY, 2013, 8Kim, Tae HyunKim, Joo-YoungSohn, Dae KyungKim, Yeon-JooLee, Yoon-SeokMoon, Sung HoKim, Sang SooKim, Dae Yong
- [42] A phase I study of BMS-582664 (brivanib alaninate), an oral dual inhibitor of VEGFR and FGFR tyrosine kinases, in combination with full-dose cetuximab in patients (pts) with advanced gastrointestinal malignancies (AGM) who failed prior therapyJOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)Garrett, C. R.Siu, L. L.Giaccone, G.El-Khoueiry, A.Marshall, J.LoRusso, P.Velasquez, L.Kollia, G.He, P.Feltquate, D.
- [43] Phase 2 randomized study evaluating safety, efficacy, and optimal dose of ABBV-400 in combination with fluorouracil, folinic acid, and bevacizumab in previously treated patients with metastatic colorectal cancerJOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)Raghav, Kanwal Pratap SinghHubert, AyalaFakih, MarwanFang, HuaAristide, Martha Raluca Neagude Almeida, Carla BiesdorfVasilopoulos, AthanasiosSui, YunxiaStrickler, John H.
- [44] Incidence of serious bleeding events (sBE) in patients (pts) with metastatic colorectal cancer (mCRC) receiving bevacizumab (BV) as part of a first-line regimen: Results from the BRiTE observational cohort study (OCS)JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)Flynn, P. J.Sugrue, M. M.Feng, S.Purdie, D. M.Grothey, A.Sargent, D. J.Berlin, J. D.Kabbinavar, F. F.Dong, W.Kozloff, M. F.
- [45] Phase 2 randomized study evaluating safety, efficacy, and optimal dose of ABBV-400 in combination with fluorouracil, folinic acid, and bevacizumab in previously treated patients with metastatic colorectal cancer.JOURNAL OF CLINICAL ONCOLOGY, 2025, 43 (4_SUPPL) : TPS308 - TPS308Raghav, Kanwal Pratap SinghHubert, AyalaFakih, MarwanFang, HuaAristide, Martha Raluca Neagude Almeida, Carla BiesdorfVasilopoulos, AthanasiosSui, YunxiaStrickler, John H.
- [46] Phase II study of high-dose somatostatin analogue in patients either previously treated or untreated who have extensive-stage small cell lung cancerAMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 1999, 22 (01): : 15 - 17Marschke, RFGrill, JPSloan, JAWender, DBLevitt, RMailliard, JAGerstner, JBGhosh, CMorton, RFJett, JR
- [47] Quality of life (QoL) in patients (pts) with locally advanced or metastatic breast cancer (MBC) previously treated with anthracyclines and taxanes who received eribulin or capecitabine: A Phase Ill, open-label, randomized studyONKOLOGIE, 2013, 36 : 97 - 97Cortes, J.Awada, A.Kaufmann, P. A.Yelle, L.Perez, E. A.Velikova, G.Wanders, J.Olivo, M.He, Y.Ductus, C.Simons, R.Bischoff, J.Twelves, C.
- [48] Effects of primary granulocyte-colony stimulating factor prophylaxis on neutropenic toxicity and chemotherapy dose delivery in Chinese patients with breast cancer who received adjuvant docetaxel plus cyclophosphamide chemotherapy: a retrospective cohort studyHONG KONG MEDICAL JOURNAL, 2022, 28 (06) : 438 - 446Kwok, Carol C. H.Wong, W. H.Chan, Landon L.Wong, Sabrina P. Y.Wang, F.Wong, Martin C. S.Tse, Shelly L. A.
- [49] CONTESSA 2: A multinational, multicenter, phase 2 study of tesetaxel plus a reduced dose of capecitabine in patients with HER2-, HR+ metastatic breast cancer (MBC) who have not previously received a taxaneCANCER RESEARCH, 2020, 80 (04)Schwartzberg, LeeAsselah, JamilBondarenko, IgorChae, YeeSooDaCosta, NoshirFeng, Yin-HsunIzarzugaza, YannLemieux, JulieLiu, Mei-ChingMarx, GavinO'Shaughnessy, JoyceOliveira, MafaldaRugo, HopeSeidman, AndrewWright, GailO'Connell, JosephWei, ThomasKim, Sung-Bae
- [50] Quality of life (QoL) in patients (pts) with locally advanced or metastatic breast cancer (MBC) previously treated with anthracyclines and taxanes who received eribulin mesylate or capecitabine: A phase III, open-label, randomized studyJOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)Cortes, JavierAwada, AhmadKaufman, Peter AndrewYelle, LouisePerez, Edith A.Velikova, GalinaWanders, JantienOlivo, Martin S.He, YiDutcus, CorinaSimons, W. RobertTwelves, Christopher